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Inflammasome: Putting the Pieces Together
Jü rgen Ruland 1, *
Microbial and danger signals result in inflammasome activation and release of inflammatory cytokines through mechanisms that remain elusive. Cai et al. and Lu et al. show that triggering of inflammasome sensors induces prion-like polymerization of the adaptor ASC into filaments. These structures function as platforms for inflammatory cytokine production and represent a unified mechanism for inflammasome assembly.
Inflammasomes are key signaling machines of the innate immune system that drive the production of the highly inflammatory cytokine interleukin-1b (IL-1b) via caspase-1 activation in response to microbial and nonmicrobial danger signals (Schroder and Tschopp, 2010) . They are composed of a danger sensor, an adaptor protein-often ASC-and caspase-1. Prototypical inflammasome sensors, such as NLRP3 and AIM2, contain a pyrin domain (PYD) that can interact with the PYD of ASC (ASC PYD ),
and ASC additionally possesses a caspase recruitment domain (CARD) for procaspase-1 engagement. Although the primary composition of the inflammasomes has been resolved and much of their physiological and pathological functions have been revealed through genetic studies, the biochemical and biophysical mechanisms of inflammasome activation remained mysterious. In this issue of Cell, two elegant reports demonstrate that AIM2 or NLPR3 triggering induces a prion-like polymerization of ASC into filaments that provide platforms for activating inflammatory cytokine production (Cai et al., 2014; Lu et al., 2014) . Prions were originally identified as the causative agents of spongiform encephalopathies in humans, but additional studies found prions also in lower organisms such as yeast (Prusiner, 1998) . These proteins are functionally defined by their ability to induce an energetically favored self-polymerization process in which an initial nucleation step converts the native protein into the polymerized form. The Chen laboratory previously identified the immune adaptor MAVS as the first beneficial prion-like protein in mammals (Hou et al., 2011) . After innate virus sensing, the RNA receptor RIG-I nucleates the N-terminal CARD of MAVS, which then undergoes prion conversion resulting in MAVS polymerization, NF-kB, and IRF3 activation. Now, the same group uses a yeast system to screen for prion-like features in additional immune signaling proteins that contain death domain (DD) folds, such as a PYD or CARD (Cai et al., 2014 Lu and colleagues use a complementary approach to investigate inflammasome assembly (Lu et al., 2014 inflammasome complex was assembled in vitro and analyzed for its stoichiometric composition and microscopic structure. Within the complex, relative few AIM2 molecules are present compared to ASC, and ASC is understoichiometric to caspase-1. The whole ternary complex is star shaped with ASC in the center and caspase-1 at the arms, and comparable inflammasome structures are observed within mammalian cells. These two studies support a unified model for ASC-dependent inflammasome activation (Figure 1) . After an insult reaches a threshold, NLRP3 or AIM2 are released from autoinhibition, allowing interaction of their PYD with the PYD of ASC. These events result in ASC prionlike nucleation, which perpetuates independently of the nucleating factor to form large stable ASC filaments that are both required and sufficient for inflammasome activation. The PYDs of ASC acts as the building block of the filaments, and the CARDs are flexibly linked to induce pro-caspase-1 polymerization and activation. Because relative few sensor molecules are sufficient to induce polymerization of relative large numbers of ASC and caspase-1 molecules and because the process is self-propagating, this mechanism allows robust signal In nonstimulated cells, the inflammasome sensors AIM2 and NLRP3 exist in an autoinhibited state. Triggering of AIM2 via intracytoplasmic DNA delivery or activation NLRP3 by multiple distinct stimuli overcome autoinhibition of the inflammasome sensors and allow their PYDs to interact with the PYD of the adaptor protein ASC. These events result in an ASC prion nucleation, which subsequently templates other ASC molecules to induce a self-perpetuating polymerization cascade that assembles ASC molecules into large fibers. Through CARD-CARD interactions between ASC and procaspase-1, the ASC polymers recruit multiple caspase-1 molecules to drive proximity-induced caspase-1 dimerization and polymerization, resulting in autocatalytic activation of its p10 and p20 subunits for inflammation.
amplification. The principle of prion-like polymerization seems to be conserved in signal transduction because a fungal NOD-like pattern recognition receptor also induces conversion of a fungal prion (Cai et al., 2014) . Moreover, filamentous signaling complexes with DD modules are observed in other inflammatory cascades such as antigen receptor signaling through CARD11/BCL10/MALT1 (Qiao et al., 2013) or in the Rig-I/MAVS pathway (Hou et al., 2011) . Still, many DD-containing immune adapters, including MyD88, do not form unrestrained polymers but rather form limited oligomers with presumably reversible organization (Lin et al., 2010) . The biophysical characteristics that dictate limited oligomer versus self-propagating polymer formation remain to be defined. Of note, not all inflammasomes utilize ASC. The sensor NLRC4, for instance, can activate caspase-1 independent of ASC after Salmonella typhimurium infection. Whether such mechanisms also involve prion-like protein conversion is unclear. Finally, because aberrant inflammasome activation is deleterious to the host (Schroder and Tschopp, 2010) , it must be counterbalanced to maintain homeostasis. Classical inflammatory pathways that are controlled by protein kinases or ubiquitin ligases are negatively regulated via phosphatases and de-ubiquitinases (Ruland, 2011) . The literature indicates that selective autophagy could remove filamentous CARD11/BCL10/MALT1 signalosomes after T cell activation (Paul et al., 2012) . In the future, it will be important to define whether similar mechanisms could also disassemble activated inflammasomes.
Synonymous mutations do not alter amino acids and are generally considered nonfunctional in cancer. Supek et al. now present a compelling analysis suggesting that such silent mutations can be oncogenic by altering transcript splicing and thereby affecting protein function.
Sporadic cancer is thought to arise from a cell of origin with accumulated somatic mutations. With thousands of cancer genomes and exomes sequenced, different categories of genomic alterations, such as somatic point mutations, loss or gain of chromosome material, and structural genome rearrangements, have been identified by comparing DNA from tumor cells with that from matching normal tissues. Point mutations are classified as synonymous versus nonsynonymous based on their ability to alter the encoded amino acids and thus affect protein function. Synonymous or silent mutations are categorized as passenger events because they do not modify the protein sequence and are thus considered functionally irrelevant, although their potential involvement in tumorigenesis has been suspected (Gartner et al., 2013) . In this issue, Ben Lehner and colleagues revisit this common perception of synonymous mutations in cancer (Supek et al., 2014) . By analyzing the catalog of somatic mutations detected in 3,851 cancer exomes and more than 400 whole genomes from 19 tumor types, they observed a 1.23-to 1.3-fold enrichment of silent mutations in oncogenes, but not in tumor suppressor genes, when compared to a set of noncancer genes with matching genomic features, including GC content, mRNA expression levels across tissues, and replication timing. As a reference, the enrichment
